Vanguard Personalized Indexing Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Vanguard Personalized Indexing Management's TXG Position: Q2 2026 in Review
Vanguard Personalized Indexing Management increased its 10x Genomics (TXG) stake by 1.5% in Q2 2026, buying an estimated $11.3K and bringing the position to 28,359 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #944.
Vanguard Personalized Indexing Management first reported a position in TXG in Q2 2021 and has held it in 16 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Vanguard Personalized Indexing Management held 28,359 shares of 10x Genomics worth $1.09M as of Q2 2026.
- Vanguard Personalized Indexing Management bought 430 10x Genomics shares in Q2 2026, an estimated $11.3K.
- 10x Genomics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #944 holding.
- Vanguard Personalized Indexing Management first reported a position in 10x Genomics in Q2 2021 and has held it in 16 quarters since.
- 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.